Pharmacogenomics of celiprolol – evidence for a role of P‐glycoprotein and organic anion transporting polypeptide 1A2 in celiprolol pharmacokinetics-Reference-Cited by-同舟云学术

Pharmacogenomics of celiprolol – evidence for a role of P‐glycoprotein and organic anion transporting polypeptide 1A2 in celiprolol pharmacokinetics

Published:2021-09-29 Issue: Volume: Page:
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clin Transl Sci

Author:

Hirvensalo Päivi¹²,Tornio Aleksi¹²³^ORCID,Tapaninen Tuija¹²³^ORCID,Paile‐Hyvärinen Maria¹²³,Neuvonen Mikko¹²,Backman Janne T.¹²³^ORCID,Niemi Mikko¹²³^ORCID

Affiliation:

1. Department of Clinical Pharmacology University of Helsinki Helsinki Finland

2. Individualized Drug Therapy Research Program Faculty of Medicine University of Helsinki Helsinki Finland

3. Department of Clinical Pharmacology, HUS Diagnostic Center Helsinki University Hospital Helsinki Finland

Funder

European Research Council

Sigrid Juséliuksen Säätiö

Biomedicum Helsinki-säätiö

Orionin Tutkimussäätiö

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.13159

Reference50 articles.

1. Celiprolol

2. Celiprolol

3. Comparative enantioselective pharmacokinetic studies of celiprolol in healthy volunteers and patients with impaired renal function;Hartmann C;Eur J Clin Pharmacol,1990

4. Celiprolol

5. Transport of celiprolol across human intestinal epithelial (Caco-2) cells: mediation of secretion by multiple transporters including P-glycoprotein

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the Clinical Drug‐Drug Interaction Potential of Pritelivir on Transporters and CYP450 Enzymes Using a Cocktail Approach;Clinical Pharmacology in Drug Development;2024-05-16

2. Sensitive detection of single-nucleotide polymorphisms by conjugated polymers for personalized treatment of hypertension;Science Translational Medicine;2023-03-08

3. Exposure of Fexofenadine, but Not Pseudoephedrine, Is Markedly Decreased by Green Tea Extract in Healthy Volunteers;Clinical Pharmacology & Therapeutics;2022-06-29

4. Transporters in Drug Development: International Transporter Consortium Update on Emerging Transporters of Clinical Importance;Clinical Pharmacology & Therapeutics;2022-06-29